Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	800.82	587.86	390.4	292.73
Revenue Growth	49.86%	50.58%	33.37%	-
Cost of Revenue	113.77	118.56	89.81	98.55
Gross Profit	687.05	469.3	300.59	194.18
Selling, General & Admin	403.06	646.46	230.97	214.64
Research & Development	141.34	368.14	100.84	110.06
Other Operating Expenses	-7.06	1.08	-	-
Operating Expenses	537.35	1,016	331.81	324.69
Operating Income	149.7	-546.37	-31.22	-130.51
Interest & Investment Income	18.68	18.68	20.57	21.7
Other Non Operating Income (Expenses)	-2.47	0.43	0.08	0.27
EBT Excluding Unusual Items	165.92	-527.26	-10.57	-108.55
Merger & Restructuring Charges	0.39	-	-0.69	-
Pretax Income	166.31	-527.26	-11.26	-108.55
Income Tax Expense	-2.01	1	0.68	-0.41
Net Income	168.31	-528.26	-11.93	-108.14
Preferred Dividends & Other Adjustments	-206.3	-104.17	-	-
Net Income to Common	374.61	-424.09	-11.93	-108.14
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	80	55	14	13
Shares Outstanding (Diluted)	84	55	14	13
Shares Change	119.05%	302.55%	4.16%	-
EPS (Basic)	4.71	-7.77	-0.88	-8.31
EPS (Diluted)	1.99	-7.77	-0.88	-8.31
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	312.97	170.73	47.96	-65.89
Free Cash Flow Per Share	3.74	3.13	3.54	-5.06
Gross Margin	85.79%	79.83%	77.00%	66.33%
Operating Margin	18.69%	-92.94%	-8.00%	-44.59%
Profit Margin	46.78%	-72.14%	-3.06%	-36.94%
Free Cash Flow Margin	39.08%	29.04%	12.29%	-22.51%
EBITDA	152.38	-544.24	-28.87	-128.39
EBITDA Margin	19.03%	-92.58%	-7.40%	-43.86%
D&A For EBITDA	2.68	2.13	2.35	2.13
EBIT	149.7	-546.37	-31.22	-130.51
EBIT Margin	18.69%	-92.94%	-8.00%	-44.59%
Advertising Expenses	-	53.6	37.3	23.8

SEC Filings: 10-K · 10-Q